Program Manual - Saint Louis University

More documents

Recommendations

Info

E. HCWs with previous BCG vaccination Tuberculin reactivity caused by BCG vaccination wanes with the passage of time and is unlikely to persist greater than 10 years after vaccination in the absence of M. tuberculosis exposure and infection. Tuberculin skin testing is not contraindicated for persons who have been vaccinated with BCG. The diagnosis of M. tuberculosis infection and the use of preventative therapy will be considered for any BCG vaccinated persons with greater than 10 millimeters induration, especially if: there is a contact with infectious tuberculosis, particularly if the infectious person has transmitted M. Tuberculosis to others, the vaccinated person was born or has resided in a country with high prevalence of tuberculosis, or the vaccinated person is continually exposed to population in which prevalence of tuberculosis is high. REFERENCE: CDC. The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States, MMWR 1996;45:8-10. F. Evaluation for Tuberculosis infection in HCWs exposed to infectious tuberculosis case HCWs are evaluated after confirmed exposure to a source case with infectious M. tuberculosis. A source case is defined as a patient with sputum, tissue, or fluid smear positive for acid fast bacilli and/or sputum, tissue, or fluid culture positive for M. tuberculosis, has chest x-ray findings which are highly suggestive of active tuberculosis, and has clinical signs and symptoms suggestive of active respiratory Tb. These findings may include new apical infiltrates and/or cavitation. Evaluation is not necessary if the sputum specimen from the source case is indicative of non-Tuberculosis mycobacteria. A HCW who insists on being evaluated after being advised that there is a low risk of exposure, may do so at Employee Health. Anyone who has had potential exposure to active tuberculosis at Saint Louis University/SLUCare/SLUHospital may receive follow up testing. 1. Definition of exposure: Close prolonged contact with the patient before patient was placed on isolation. 2. Infection Control will send the Infection Control Memo confirming the exposure to the supervisors of involved departments. 3. Supervisors MUST send a list to Employee Health of all exposed HCWs as defined in the Infection Control Memo. Supervisors must respond to Employee Health even if no HCW exposures occurred within the department. 4. Post-exposure Evaluation Process a. PPD status negative or PPD status unknown: 1) Baseline PPD testing -- The HCW should have a baseline PPD test within in six months prior to exposure. 2) Post-exposure testing – The HCW should have a 10 weeks post-exposure PPD (Mantoux) test. b. PPD status positive: Tuberculosis screening questionnaire is administered. 1) If the HCW is asymptomatic, the HCW is cleared to continue patient care/work. 2) If the HCW is symptomatic, a chest x-ray is provided by Employee Health. HCW is evaluated at Employee Health. a) If the chest x-ray is negative, the HCW is cleared to continue patient care/work. b) If the chest x-ray is positive, the HCW is evaluated and treated through Employee Health. The HCW is cleared to continue patient care/work when the infectious status is known to be non-communicable. c. If follow up is done elsewhere, documentation of the HCW’s infectious status and supporting evidence is to be sent to Employee Health. G. Positive PPD recent converter HCW follow up A recent converter in a HCW is defined as a > 10 mm increase in size of induration within a 2 year period. Follow up evaluation is available at Employee Health. This includes an evaluation for tuberculosis disease, information on risk of contracting tuberculosis disease, signs/symptoms of disease, and anti-tuberculosis prophylaxis. Evaluation and preventative therapy are offered at no expense to the HCW if they are evaluated and followed at Employee Health. Positive PPD test results are reported to the Health Department. HCWs may have follow up done elsewhere. Documentation of the follow up must be sent to Employee Health for review. E-15
H. HCWs with active tuberculosis disease HCWs are unable to work until they are non-infectious. Documentation must be provided showing two weeks of effective therapy for active pulmonary tuberculosis are complete with a good clinical response. The HCW is cleared to continue patient care/work when the infectious status is known to be non-communicable. I. HCW NON-COMPLIANCE HCW compliance with Tuberculosis Screening programs is mandatory. This includes: pre-placement tuberculosis screenings and 2 step PPD testing, annual tuberculosis screening, increased risk department semi-annual tuberculosis screening, and post-exposure tuberculosis screening. 1. Employee Health manager or physician will notify Human Resources or the department director that the HCW is not compliant. Human Resources or the department director will proceed according to individual company policy to resolve the non-compliance issues. Depending on company policy the HCW may be relieved from duty until the compliance issue is resolved. 2. The Employee Health manager or physician will notify Human Resources when the HCW is compliant. J. Guidelines for interpreting a tuberculin skin test 1. A tuberculin reaction of five millimeters or greater of induration is classified as positive in the following groups: a. HIV-infected persons b. Recent contacts of TB case c. Persons with fibrotic changes on chest radiograph consistent with old healed TB d. Patients with organ transplants and other immunosuppressed patients (receiving the equivalent of > 15 mg/day of prednisone for > 1 month). 2. A tuberculin reaction of 10 millimeters or greater of induration is classified as positive in persons who do not meet the preceding criteria but who have other risk factors for Tuberculosis. These include: a. Recent arrivals to the U.S. (< 5 years) from high-prevalence countries b. Injection drug users c. Residents and employees of high risk congregate settings (correctional facilities, nursing homes, homeless shelters, SLUCares, residential facilities) d. Mycobacteriology laboratory personnel e. Persons with medical conditions that place them at high risk (HIV infection; substance abuse; recent infection with M. tuberculosis; chest radiograph findings suggestive of previous TB; diabetes mellitus; silicosis; prolonged corticosteroid therapy and other immunosuppressive therapy; cancer of the head and neck; hematologic and reticuloendothelial diseases; end-stage renal disease; intestinal bypass or gastrectomy; chronic malabsorption syndromes; or low body weight) f. Children < 4 years of age g. Children and adolescents exposed to adults in high-risk categories 3. A tuberculin reaction of 15 millimeters or greater of induration is classified as positive in persons with no known risk factors for TB. REFERENCE: Core Curriculum on Tuberculosis, 4th Edition, 2000, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. “November 2001 – The Internet (HTML) version of the Core Curriculum on Tuberculosis is updated periodically. Therefore, the Internet version may differ from the print version.” Retrieved 12-09-04 E-16
Page 1 and 2:
Advanced Dental Education Program i
Page 3 and 4:
GRADUATE ORTHODONTICS PROGRAM MANUA
Page 5 and 6:
The Center For Advanced Dental Educ
Page 7 and 8:
This effort leads to the preparatio
Page 9 and 10:
Dr. Peter H. Buschang (Adjunct Prof
Page 11 and 12:
Dr. Jason Cope (Adjunct Associate P
Page 13 and 14:
Dr. Ernst Taeger (Adjunct Professor
Page 15 and 16:
Saint Louis University Graduate Sch
Page 17 and 18:
SAINT LOUIS UNIVERSITY Center for A
Page 19 and 20:
SERVICE 7. Inculcate both the abili
Page 21 and 22:
• utilize appropriate infection c
Page 23 and 24:
Course List 2009 501 Fundamentals o
Page 25 and 26:
SAINT LOUIS UNIVERSITY CENTER FOR A
Page 27 and 28:
A. Respect for all individuals in t
Page 29 and 30:
at Saint Louis University. Procedur
Page 31 and 32:
• sharing dental or personal deta
Page 33 and 34:
Center For Advanced Dental Educatio
Page 35 and 36:
26 — Admission Policies and Proce
Page 37 and 38:
28 — Admission Policies and Proce
Page 39 and 40:
Acquittal or exoneration of a membe
Page 41 and 42:
E. Members should become familiar w
Page 43 and 44:
C. Members should pursue changes in
Page 45 and 46:
D. INSTRUCTOR ASSIGNMENT 1. The Cli
Page 47 and 48:
E. PATIENT RECORDS Patient records,
Page 49 and 50:
VI. RETAINERS AND POSITIONERS A. Th
Page 51 and 52:
IX. LIBRARY 4. No food or drink all
Page 53 and 54:
XI. EMERGENCY CARE OF PATIENTS A. D
Page 55 and 56:
7 date/time 8 restores 9 n/a D. Cal
Page 57 and 58: addition to the 70 required credit
Page 59 and 60: 4 ORTHODONTIC POLICY MANUAL FOR 200
Page 61 and 62: 2. An abstract of the finished thes
Page 67 and 68: 3. Requests for leave immediately p
Page 69 and 70: G. Penalty Excessive tardiness or a
Page 71 and 72: Contact Information Course Instruct
Page 73 and 74: Guidelines for the Initial Dental R
Page 75 and 76: Commission on Dental Accreditation
Page 77 and 78: . determining that the program may
Page 79 and 80: iii. Personal Hygiene iv. Saint Lou
Page 81 and 82: After use, the disposable sharp or
Page 83 and 84: work area. PPEs must remain on duri
Page 85 and 86: Disinfection: To render free of inf
Page 87 and 88: 7. Bulk disposal items, such as cem
Page 89 and 90: 7. Storage and Transport of Contami
Page 91 and 92: 3. Labeled or color-coded in accord
Page 93 and 94: iii. Personal Hygiene A. Hand Washi
Page 95 and 96: I. Pre-Placement Evaluation A. Medi
Page 97 and 98: C. Tetanus: One of #1 - #3 must be
Page 99 and 100: an “expanded” three drug regime
Page 101 and 102: h. Six week follow up: Appointment
Page 103 and 104: 3. Hepatitis C Virus a. Risk assess
Page 105 and 106: J. Pediculosis (Lice) 1. Definition
Page 107: 5. HCWs who are PPD status positive
Page 111 and 112: L. Pertussis: HCW is relieved from
Page 113 and 114: C. Employee Health Department Repor
Page 115: SAINT LOUIS UNIVERSITY CENTER FOR A
Page 118 and 119: Legal Issues adequacy of clinical r
Page 120 and 121: getting your picture taken that fir
Page 122 and 123: Much activity is taking place in th
Page 124 and 125: ORTHODONTIC INSTRUMENT LIST 2009 Th
Page 126 and 127: (1) Tweed hollow chop plier with Tw
Page 128 and 129: FIRST YEAR GRADUATE ORTHODONTIC RES
Page 130 and 131: HENRY SCHEIN, INC. 5 Harbor Park Dr
Page 132 and 133: CENTER FOR ADVANCED DENTAL EDUCATIO
Page 134 and 135: SAINT LOUIS UNIVERSITY CENTER FOR A
Page 139: Application for American Associatio
Page 142 and 143: The American Board of Orthodontics
Page 148 and 149: Maps Directions I HSC Library I Sai
Page 150 and 151: DEMKO, Dr. Richard Assoc. Clinic Pr
Page 152 and 153: MILLER, Dr. Jackie 1015 G Washingto
Page 157: Mathina. Donna 4704 Candace Dr. St.
Page 160 and 161:
REGISTRATION You will be for three
Page 162 and 163:
Dear Orthodontic Residents: I am pl
Page 164 and 165:
MEMO To: New Residents From: Kathy
Page 166 and 167:
SAINT LOUIS UNIVERSITY CENTER FOR A
Page 168 and 169:
Asha Madhavji 1005 Mississippi Ave.
Page 170 and 171:
i Dan Lovell 1415 Dorothy Ave. Alto
Page 172:
LONG DISTANCE CODE You will need to
Page 178 and 179:
SAINT LOUIS UNIVERSITY Department o
Page 180 and 181:
o ARTICULATORS Al\l) FACEBOWS - The
Page 182 and 183:
American Vision LP Instrument MISCA
Page 184 and 185:
The Center for Advanced Dental Educ
Page 186 and 187:
Page 188 and 189:
Page 190:
• The Center for Advanced Dental
Page 193 and 194:
July 1, 2009 Dear Colleague: 1402 S
Page 195 and 196:
c. Protection is afforded to each p
Page 197 and 198:
occur during the providing of emerg
Page 199 and 200:
combined aggregate. Insurance prote
Page 201 and 202:
SLU Mission Statement The Mission o
Page 203:
General Information THE UNIVERSITY
Page 208 and 209:
10 - General Information is availab
Page 210 and 211:
THE GRADUATE SCHOOL Administration
Page 212 and 213:
History [Department of History]: M.
Page 214 and 215:
Admission Policies and Procedures A
Page 216 and 217:
applicant forwards transcripts and/
Page 218:
TUITION/FEES/DEPOSITS Tuition and f
Page 221 and 222:
22 - AdmissionPolicies and Procedur
Page 223 and 224:
24 Admission Policies and Procedure
Page 225 and 226:
26 Admission Policies and Procedure
Page 227:
28 - Admission Policies and Procedu
Page 230 and 231:
nation will not be scheduled during
Page 232 and 233:
Upon authorization by the Graduate
Page 234 and 235:
envisioned. In particular, the draf
Page 237 and 238:
38 6CR5: Doctor of Philosophy Degre
Page 239 and 240:
and the writing and defense of a th
Page 241 and 242:
sis and treatment of patients at th
Page 243 and 244:
HEALTH CARE ETHICS James M. DuBois,
Page 245 and 246:
Health Care Ethics identify major a
Page 247 and 248:
University Administration and Gradu
Page 249 and 250:
Peter Bernhardt Ph.D., University o
Page 251 and 252:
Noelle Fearn Ph.D., University of M
Page 253 and 254:
David Kaplan Ph.D., University of I
Page 255 and 256:
Paul A. Meluik D.D.S .• Washingto
Page 257:
KeVlll Rowland Ph.D., West Virginia
Page 260:
160 Administration and Graduate Fac
Page 263:
Health Management and Policy, Depar
show all

Program Manual - Saint Louis University

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?